BACKGROUND: Acute exacerbations of chronic bronchitis (AECB) are recurrent and
potentially severe medical events for the 13 million people in the United States who have …

Background: Acute exacerbation of chronic bronchitis (AECB) is a common condition, with
substantial associated costs and morbidity. Research efforts have focused on innovations …

The social, medical and economic effects of acute bacterial exacerbations of chronic
bronchitis on individual patients and the resource implications of this disease for the …

Chronic bronchitis is a common problem affecting a large proportion of the adult population.
People with chronic bronchitis are subject to recurrent attacks of bronchial inflammation …

Limited data exist to guide physicians in the cost-effective treatment of acute exacerbation of
chronic bronchitis (AECB). Therefore, the main objective of this study was to determine the …

The treatment of community‐acquired respiratory tract infections, such as acute
exacerbations of chronic bronchitis (AECB), constitutes a huge socioeconomic burden. In …

Background The antibacterial activity, tolerability profile and duration of treatment associated
with antibiotics are important therapy attributes when considering treating patients for lower …

Background: Acute exacerbation of chronic bronchitis (AECB) places tremendous burden on
patients, providers, employers, and health care systems. Objective: The purpose of this …

Objective To evaluate the costs, consequences, effectiveness, and safety of ciprofloxacin vs
standard antibiotic care in patients with an initial acute exacerbation of chronic bronchitis …

Background Although exacerbations are the main cause of medical visits and
hospitalizations of patients with chronic bronchitis and COPD, little information is available …